Induction of connective tissue growth factor accounts for the inability of glucocorticoid suppression on pulmonary fibrosis

Clin Transl Med. 2022 May;12(5):e867. doi: 10.1002/ctm2.867.

Authors

Zhaoni Wang¹, Xiangsheng Yang¹, Xin Xu¹, Qingyang Yu¹, Yang Peng¹, Jianxing He¹, Nanshan Zhong^{1

2}, Xiao Xiao Tang^{1

2}

Affiliations

¹ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
² Guangzhou Laboratory, Bio-island, Guangzhou, Guangdong, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Connective Tissue Growth Factor / genetics
Glucocorticoids / therapeutic use
Humans
Pulmonary Alveoli / metabolism
Pulmonary Fibrosis* / drug therapy
Pulmonary Fibrosis* / metabolism

Substances

Glucocorticoids
Connective Tissue Growth Factor